Kiara Taylor has worked as a financial analyst for more than a decade. Her career has involved a number of financial firms, including Fifth Third Bank, JPMorgan, and Citibank. She has filled a number ...
Zacks Small Cap Research on MSN

CVKD: Designing phase 3 trial for CAD-1005 in HIT

By David Bautz, PhD NASDAQ: CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Planning for Phase 3 Registration Trial ...
The oral presentation, titled, “¹⁸⁶Rhenium-Nanoliposomes (¹⁸⁶RNL) for the Treatment of Leptomeningeal Metastases: Translational Insights from Clinical and Preclinical Models,” was delivered by ...
Cloud-Clone has built an integrated antibody R&D and manufacturing platform, focusing on enhancing product consistency and MP for research and diagnostics. HUSTON, TX, UNITED STAT ...
Chantle Edillor used a fascination with sourdough starters to pivot from studying human diseases to exploring yeast-based ...
Cubit Diagnostics today announced it has closed its latest round of SAFE (Simple Agreement for Future Equity) financing. The proceeds will fund the company's next phase of work, centered on locking in ...
When this is done well, biomarkers accelerate decision-making, reduce uncertainty, and ultimately bring improved therapies to patients faster. When this is done poorly, however, biomarkers can add ...
New service offering enables GR/NF-κB transrepression studies to support deeper mechanism-of-action insight in drug ...
Enzyme assays are evolving from traditional spectrophotometric methods to high-throughput, AI-powered platforms that accelerate drug discovery, diagnostics, and sustainable chemistry. Advances like ...
LiquidCell Dx, a next generation cancer diagnostics company, today announced publication in Nature of critical research underpinning the development of LiquidTME, its blood-based assay for tumor ...
The two partners will collaborate on the customization of IMSR Plants to be integrated with Riot developed and operated data centers. This partnership combines Terrestrial Energy's nuclear plant ...
Smaller life science plays adopting AI in earnest are attracting increased investor attention – but they need to keep their ...